References
- Chandrasekaran VRM, Hsu D-Z, Liu M-Y. (2009). The protective effect of sesamol against mitochondrial oxidative stress and hepatic injury in acetaminophen-overdosed rats. Shock 32:89–93
- Claridge LC, Eksteen B, Smith A, et al. (2010). Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults. BMJ 341:c6764
- Court MH, Freytsis M, Wang X Peter I, et al. (2013). The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C.G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failures. J Pharmacol Exp Ther 345:297–307
- Court MH, Greenblatt DJ. (1997). Biochemical basis for deficient paracetamol glucuronidation in cats: an interspecies comparison of enzyme constraint in liver microsomes. J Pharm Pharmacol 49:446–9
- Dart RC, Bailey E. (2007). Does therapeutic use of acetaminophen cause acute liver failure? Pharmacotherapy 27:1219–30
- Fontana RJ. (2008). Acute liver failure including acetaminophen overdose. Med Clin North Am 92:761–94
- Hanioka N, Yamamoto M, Iwabu H, et al. (2007). Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes. Life Sci 81:1436–45
- Heard K, Green JL, Anderson V, et al. (2014). A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration. BMC Pharmacol Toxicol 15:1–11
- Kevala T, Ćavar I, Čulo F. (2010). Influence of small doses of various drug vehicles on acetampinophen-induced liver injury. Can J Physiol Pharmacol 88:960–7
- Kevala T, Ćavar I, Čulo F. (2011). Biological actions of drug solvents. Period Biol 113:311–20
- Laine JE, Auriola S, Pasanen M, Juvonen RO. (2009). Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. Xenobiotica 39:11–21
- Larson AM, Polson J, Fontana RJ, et al. (2005). Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42:1364–72
- Lee WM. (2007). Acetaminophen toxicity: changing perceptions on a social/medical issue. Hepatology 46:966–70
- Manyike PT, Kharasch ED, Kalhorn TF, Slattery JT. (2000). Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther 67:275–82
- Martignoni M, Geny MM, Groothuis GMM, de Kanter R. (2006). Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2:875–94
- McGill MR, Jaeschke H. (2013). Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res 30:2174–87
- McGill MR, Williams CD, Xie Y, et al. (2012). Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharm 264:387–94
- Meister A. (1988). Glutathione metabolism and its selective modification. J Biol Chem 263:17205–8
- Mitchell JR, Jollow DJ, Potter WZ, et al. (1973). Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 187:211–17
- Nishimura Y, Kurat N, Iwase M, et al. (1999). The effects of organic solvents on trimethadione N-demethylation in rats. Res Commun Mol Path 104:229–39
- Salem SI, Elgayed SSA, El-Kelany WM, Abd El-Baky AA. (2010). Diagnostic studies on acetaminophen toxicosis in dogs. Global Veterinaria 5:72–83
- Sharer JE, Shipley LA, Vandenbranden MR, et al. (1995). Comparisons of Phase I and Phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metab Dispos 23:1231–41
- Smolarek TA, Higgins CV, Amacher DE. (1990). Metabolism and cytotoxicity of acetaminophen in hepatocyte cultures from rat, rabbit, dog, and monkey. Drug Metab Dispos 18:659–63
- Stevens JC, Shipley LA, Cashman JR, et al. (1993). Comparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities. Drug Metab Dispos 21:753–60
- Thompson RA, Isin EM, Li Y, et al. (2012). In vitro approach to assess the potential for risk of idiosyncratic adverse reaction caused by candidate drugs. Chem Res Toxicol 25:1616–32
- Watkins PB, Kaplowitz N, Slattery JT, et al. (2006). Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 296:87–93